AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Baudax Bio, Inc.

$0 +$0.00 (+900.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
4.36K
AVG Volume
3.76K
Trailing/Forward PE
-0/0
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
0500K1M1.5M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
23 Q3310K
23 Q2548K
23 Q1848K
22 Q41.27M
22 Q31.36M
22 Q21.4M
22 Q11.3M
21 Q41.08M
21 Q3756K
21 Q2543K
Net Income (USD) · TTM
-80M-60M-40M-20M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q3-7.16M
23 Q2-34.43M
23 Q1-34.58M
22 Q4-58.8M
22 Q3-20.11M
22 Q2-7.87M
22 Q1-15.67M
21 Q4-19.77M
21 Q3-66.25M
21 Q2-37.6M
Operating Income (USD) · TTM
-75M-50M-25M025M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q3-22.11M
23 Q2-23.91M
23 Q1-20.64M
22 Q4-23.57M
22 Q315.04M
22 Q22.23M
22 Q1-10.31M
21 Q4-19.01M
21 Q3-65.5M
21 Q2-36.86M
EBITDA (USD) · TTM
-80M-60M-40M-20M020M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q3-21.7M
23 Q2-44.3M
23 Q1-44.03M
22 Q4-46.29M
22 Q3-15.98M
22 Q2167K
22 Q1-7.86M
21 Q4-14.65M
21 Q3-70.2M
21 Q2-73.93M
Cash Flows (USD) · TTM
-60M-40M-20M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q3-14.33M
23 Q2-15.78M
23 Q1-19.55M
22 Q4-27.79M
22 Q3-36.78M
22 Q2-45.46M
22 Q1-48.3M
21 Q4-49.47M
21 Q3-51.66M
21 Q2-51.21M
EPS (USD) · TTM
-2000-1500-1000-500050021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q3-9.23
23 Q2-107.63
23 Q1-148.07
22 Q4-279.85
22 Q3133.68
22 Q2-48.82
22 Q1-294.07
21 Q4-545.6
21 Q3-1534.27
21 Q2-385.06
Expenses (USD) · TTM
020M40M60MR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q317.17M
23 Q215.36M
23 Q115.14M
22 Q418.1M
22 Q327.14M
22 Q235.32M
22 Q143.02M
21 Q448.64M
21 Q350.31M
21 Q254.12M
Shares Outstanding (USD) · TTM
-8M-6M-4M-2M02MBuybacks (Repurchases)Stock-Based Compensation21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
BXRXQ Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q3-856K
23 Q2-879K
23 Q1-976K
22 Q4-1.28M
22 Q3-1.71M
22 Q2-2.35M
22 Q1-2.96M
21 Q4-4.79M
21 Q3-6.04M
21 Q2-7.61M
Employee Count
0204060802019202020212022
BXRXQ Employee Count by quarter
PeriodEmployee Count
20229
202180
202057
201924
Free Cash Flow Yield
-200000000%-150000000%-100000000%-50000000%0%med -17923263.36%Jan 25May 25Sep 25Jan 26May 26Sep 26
BXRXQ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1792326.39%
Sep 26-1792326.39%
Aug 26-1792326.39%
Aug 26-179232633.63%
Aug 26-1792326.39%
Aug 26-179232633.63%
Jul 26-179232633.63%
Jul 26-1792326.39%
Jul 26-1792326.39%
Jul 26-1792326.39%
Jul 26-1792326.39%
Jun 26-1792326.39%
Jun 26-1792326.39%
Jun 26-1792326.39%
Jun 26-179232633.63%
May 26-1792326.39%
May 26-1792326.39%
May 26-1792326.39%
May 26-1792326.39%
May 26-1792326.39%
Apr 26-1792326.39%
Apr 26-179232633.63%
Apr 26-1792326.39%
Apr 26-1792326.34%
Mar 26-17923263.36%
Mar 26-17923263.36%
Mar 26-17923263.36%
Mar 26-17923263.36%
Feb 26-17923263.36%
Feb 26-179232633.63%
Feb 26-17923263.36%
Feb 26-179232633.63%
Jan 26-17923263.36%
Jan 26-179232633.63%
Jan 26-179232633.63%
Jan 26-17923263.36%
Jan 26-17923263.36%
Dec 25-179232633.63%
Dec 25-17923263.36%
Dec 25-179232633.63%
Dec 25-179232633.63%
Nov 25-17923263.36%
Nov 25-17923263.36%
Nov 25-17923263.36%
Nov 25-17923263.36%
Oct 25-17923263.36%
Oct 25-17923263.36%
Oct 25-17923263.36%
Oct 25-17923263.36%
Oct 25-179232633.63%
Sep 25-17923263.36%
Sep 25-17923263.36%
Sep 25-17923263.36%
Sep 25-179232633.63%
Aug 25-17923263.36%
Aug 25-17923263.36%
Aug 25-179232633.63%
Aug 25-17923263.36%
Aug 25-17923263.36%
Jul 25-17923263.36%
Jul 25-17923263.36%
Jul 25-17923263.36%
Jul 25-17923263.36%
Jun 25-17923263.36%
Jun 25-17923263.36%
Jun 25-17923263.36%
Jun 25-17923263.36%
May 25-17923263.36%
May 25-1792326.34%
May 25-17923263.36%
May 25-17923263.36%
May 25-17923263.36%
Apr 25-17923263.36%
Apr 25-17923263.36%
Apr 25-17923263.36%
Apr 25-17923263.36%
Mar 25-17923263.36%
Mar 25-179232633.63%
Mar 25-17923263.36%
Mar 25-17923263.36%
Feb 25-17923263.36%
Feb 25-17923263.36%
Feb 25-17923263.36%
Feb 25-17923263.36%
Jan 25-17923263.36%
Jan 25-17923263.36%
Jan 25-179232633.63%
Jan 25-17923263.36%
Jan 25-17923263.36%
Dec 24-17923263.36%
Dec 24-179232633.63%
Dec 24-179232633.63%
Dec 24-179232633.63%
Nov 24-1792326.39%
Nov 24-1792326.39%
Nov 24-1792326.39%
Nov 24-1792326.39%
Nov 24-1792326.39%
Oct 24-1792326.34%
Oct 24-896163.19%
Price to Sales
0000.01med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BXRXQ Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240.01
EV/EBITDA
22.52527.53032.5med 27.15Sep 22Oct 22Oct 22Nov 22Nov 22Dec 22Dec 22
BXRXQ EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 2223.43
Dec 2223.04
Dec 2226.55
Dec 2225.68
Nov 2226.96
Nov 2226.77
Nov 2227.15
Nov 2229.34
Oct 2229.68
Oct 2228.98
Oct 2230.25
Oct 2230.78
Sep 2231.54
Price to Book
00.20.40.6med 0.28Apr 22May 22Jul 22Aug 22Sep 22Nov 22Dec 22
BXRXQ Price to Book by quarter
PeriodPrice to Book
Dec 220.1
Dec 220.08
Dec 220.22
Dec 220.19
Nov 220.24
Nov 220.23
Nov 220.24
Nov 220.33
Oct 220.34
Oct 220.32
Oct 220.37
Oct 220.39
Sep 220.42
Sep 220.17
Sep 220.2
Sep 220.22
Sep 220.21
Aug 220.42
Aug 220.47
Aug 220.5
Aug 220.49
Jul 220.46
Jul 220.48
Jul 220.5
Jul 220.57
Jul 220.55
Jun 220.14
Jun 220.14
Jun 220.13
Jun 220.14
May 220.14
May 220.14
May 220.2
May 220.24
Apr 220.28
Apr 220.3
Apr 220.34
Apr 220.33
Apr 220.32
Baudax Bio, Inc.
BXRXQ
Stockpicker

Video analysis: BXRXQ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.